Strategic Asset Expansion
Mystic Asset Management Acquires Positions in Merck, Kinder Morgan, and Darden Restaurants
Key Points
Mystic Asset Management disclosed a Merck KGaA stake by purchasing 22,899 shares worth about $2.943 million in Q2; the stock opened at $162.12 and has traded in a 52-week range of $116.68 to $175.56.
Mystic bought 98,857 shares of Kinder Morgan Canada Limited for about $3.16 million in Q2; the stock’s technicals show a 50-day and 200-day moving average of $10.88 and it opened at $10.88, with a 12-month low/high of $8.05/$35.53.
In Albemarle Corporation, Mystic established a new stake of 5,686 shares valued around $768,000 in Q2; Albemarle also announced a quarterly dividend of $0.41 per share payable Oct. 1, with a record date Sept. 11.
Darden Restaurants CEO Ricardo Cardenas sold 39,134 shares on July 28 at an average price of $209.06, totaling about $8.18 million, reducing his direct ownership to 86,146 shares valued at roughly $18.01 million.
Mystic Asset Management Inc. made a flurry of new bets across American and international stocks in the second quarter, snapping up positions in four major companies worth between roughly $768,000 and $3.16 million each. The fund's shopping spree included stakes in the pharmaceutical giant Merck KGaA, the energy infrastructure player Kinder Morgan Canada Limited, battery-materials maker Albemarle Corporation, and restaurant operator Darden Restaurants, according to Watchlist News. The moves signal Mystic's push to diversify its portfolio across sectors ranging from healthcare to energy to consumer dining.
Merck KGaA and Kinder Morgan Become Top Buys
Mystic's largest Q2 purchase was 98,857 shares of Kinder Morgan Canada Limited for about $3.16 million, marking a significant bet on energy infrastructure in Canada, per Watchlist News. The stock opened at $10.88 and has a 12-month range of $8.05 to $35.53. Just behind that, Mystic bought 22,899 shares of Merck KGaA for approximately $2.94 million, adding to the pharmaceutical maker's growing investor interest. Merck KGaA stock opened at $162.12 and trades within a 52-week band of $116.68 to $175.56.
Smaller Stakes in Albemarle and Darden Restaurants
Mystic also established a new position in Albemarle Corporation with 5,686 shares valued around $768,000, betting on the battery-materials supplier amid growing demand for energy storage, according to Watchlist News. That same quarter, Albemarle announced a quarterly dividend of $0.41 per share, payable October 1 with a record date of September 11. Additionally, Mystic purchased 11,522 shares of Darden Restaurants for about $2.37 million, gaining exposure to the casual-dining sector as other funds also adjusted their stakes in the restaurant operator.
Mystic's Broader Q2 Investment Blitz
Mystic's four-stock buying spree was part of a much larger Q2 shopping run. In the same period, the fund also purchased stakes in Chevron Corporation ($3.92 million), Realty Income Corporation ($2.24 million), Rockwell Automation ($1.18 million), XPO Inc. ($1.11 million), and Keysight Technologies ($608,000), per Watchlist News. The pattern shows Mystic methodically building a diversified portfolio across energy, industrials, technology, and consumer sectors, signaling confidence in these industries heading into the second half of the year.
Darden CEO Unloads Shares as Fund Accumulates
While Mystic was buying into Darden Restaurants, the company's CEO Ricardo Cardenas moved in the opposite direction. On July 28, Cardenas sold 39,134 shares at an average price of $209.06, netting about $8.18 million and reducing his direct ownership to 86,146 shares worth roughly $18.01 million, according to Watchlist News. The insider sale came just weeks after Mystic's quarter-end purchase, highlighting a divergence in near-term sentiment between the fund and company leadership.
Sentiment
Mostly PositivePublishers
29
Articles
13
Reach
42
